Krish Krishnan, Krystal Biotech CEO

Der­ma­tol­ogy biotech Krys­tal set­tles law­suit from for­mer part­ner as it pre­pares first FDA pitch

Krys­tal Biotech’s le­gal trou­bles with a small part­ner are over.

The Pitts­burgh com­pa­ny set­tled its trade se­crets dis­pute with Pe­ripha­Gen on Tues­day, agree­ing to pay …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.